J B Chemicals and Pharmaceuticals Ltd
NSE:JBCHEPHARM
J B Chemicals and Pharmaceuticals Ltd
NSE:JBCHEPHARM
Price:
1 573.7
INR
-2.43%
Market Closed
Market Cap:
245B
INR
Balance Sheet
Balance Sheet Decomposition
J B Chemicals and Pharmaceuticals Ltd
J B Chemicals and Pharmaceuticals Ltd
| Current Assets | 19.1B |
| Cash & Short-Term Investments | 4.3B |
| Receivables | 8.2B |
| Other Current Assets | 6.7B |
| Non-Current Assets | 21.2B |
| Long-Term Investments | 361.7m |
| PP&E | 6.4B |
| Intangibles | 14.2B |
| Other Non-Current Assets | 224.6m |
Balance Sheet
J B Chemicals and Pharmaceuticals Ltd
J B Chemicals and Pharmaceuticals Ltd
Currency: INR
Millions
Annual
| Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
111
|
94
|
87
|
279
|
354
|
290
|
287
|
565
|
769
|
882
|
|
| Cash |
111
|
94
|
87
|
218
|
202
|
0
|
253
|
547
|
500
|
647
|
|
| Cash Equivalents |
0
|
0
|
0
|
61
|
152
|
290
|
34
|
18
|
269
|
235
|
|
| Short-Term Investments |
4 392
|
2 479
|
2 274
|
3 846
|
3 636
|
3 367
|
6 689
|
12
|
1 923
|
3 714
|
|
| Total Receivables |
2 441
|
2 752
|
2 680
|
3 156
|
3 320
|
3 742
|
4 125
|
6 206
|
7 948
|
8 602
|
|
| Accounts Receivables |
2 403
|
2 726
|
2 660
|
3 007
|
3 082
|
3 454
|
3 890
|
5 557
|
5 762
|
6 874
|
|
| Other Receivables |
38
|
26
|
20
|
149
|
238
|
288
|
235
|
649
|
2 186
|
1 728
|
|
| Inventory |
1 442
|
1 915
|
2 044
|
2 270
|
2 576
|
2 887
|
3 512
|
4 411
|
4 441
|
5 138
|
|
| Other Current Assets |
853
|
921
|
864
|
921
|
625
|
446
|
914
|
1 554
|
199
|
197
|
|
| Total Current Assets |
9 240
|
8 161
|
7 949
|
10 472
|
10 512
|
10 732
|
15 526
|
12 749
|
15 280
|
18 533
|
|
| PP&E Net |
3 585
|
5 057
|
6 010
|
5 811
|
5 595
|
5 842
|
5 697
|
5 668
|
5 764
|
6 349
|
|
| PP&E Gross |
0
|
5 057
|
6 010
|
5 811
|
5 595
|
5 842
|
5 697
|
5 668
|
5 764
|
6 349
|
|
| Accumulated Depreciation |
0
|
3 058
|
3 503
|
4 046
|
4 534
|
5 157
|
5 381
|
5 829
|
6 435
|
7 004
|
|
| Intangible Assets |
18
|
162
|
290
|
227
|
234
|
301
|
321
|
6 714
|
13 223
|
13 885
|
|
| Goodwill |
169
|
531
|
531
|
531
|
531
|
531
|
575
|
575
|
575
|
575
|
|
| Note Receivable |
165
|
226
|
92
|
100
|
59
|
36
|
56
|
120
|
299
|
192
|
|
| Long-Term Investments |
2 284
|
2 335
|
1 860
|
501
|
960
|
696
|
131
|
175
|
274
|
285
|
|
| Other Long-Term Assets |
2
|
4
|
7
|
9
|
29
|
68
|
76
|
74
|
124
|
123
|
|
| Other Assets |
169
|
531
|
531
|
531
|
531
|
531
|
575
|
575
|
575
|
575
|
|
| Total Assets |
15 464
N/A
|
16 477
+7%
|
16 740
+2%
|
17 651
+5%
|
17 919
+2%
|
18 206
+2%
|
22 381
+23%
|
26 074
+17%
|
35 539
+36%
|
39 941
+12%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
712
|
909
|
990
|
1 104
|
1 174
|
1 680
|
1 869
|
2 245
|
2 386
|
3 563
|
|
| Accrued Liabilities |
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
67
|
33
|
33
|
62
|
0
|
280
|
153
|
|
| Current Portion of Long-Term Debt |
1 266
|
1 934
|
489
|
226
|
225
|
312
|
336
|
339
|
1 459
|
3 290
|
|
| Other Current Liabilities |
962
|
1 468
|
1 334
|
1 354
|
1 010
|
1 108
|
1 185
|
1 253
|
1 419
|
1 675
|
|
| Total Current Liabilities |
2 940
|
4 311
|
2 812
|
2 751
|
2 442
|
3 133
|
3 453
|
3 837
|
5 544
|
8 682
|
|
| Long-Term Debt |
4
|
0
|
0
|
0
|
0
|
12
|
51
|
206
|
3 985
|
333
|
|
| Deferred Income Tax |
175
|
168
|
105
|
324
|
569
|
547
|
568
|
476
|
1 028
|
1 492
|
|
| Minority Interest |
0
|
17
|
22
|
28
|
28
|
25
|
37
|
45
|
0
|
0
|
|
| Other Liabilities |
120
|
142
|
165
|
133
|
79
|
134
|
175
|
169
|
177
|
201
|
|
| Total Liabilities |
3 239
N/A
|
4 638
+43%
|
3 104
-33%
|
3 235
+4%
|
3 118
-4%
|
3 851
+24%
|
4 284
+11%
|
4 733
+10%
|
10 735
+127%
|
10 708
0%
|
|
| Equity | |||||||||||
| Common Stock |
170
|
170
|
170
|
167
|
160
|
155
|
155
|
155
|
155
|
155
|
|
| Retained Earnings |
11 486
|
11 208
|
12 998
|
13 725
|
14 155
|
13 756
|
17 376
|
20 582
|
23 988
|
28 089
|
|
| Additional Paid In Capital |
565
|
508
|
508
|
508
|
508
|
508
|
508
|
508
|
697
|
1 134
|
|
| Unrealized Security Profit/Loss |
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
|
| Other Equity |
0
|
50
|
42
|
12
|
25
|
66
|
55
|
94
|
40
|
149
|
|
| Total Equity |
12 224
N/A
|
11 838
-3%
|
13 637
+15%
|
14 416
+6%
|
14 801
+3%
|
14 355
-3%
|
18 097
+26%
|
21 341
+18%
|
24 804
+16%
|
29 233
+18%
|
|
| Total Liabilities & Equity |
15 464
N/A
|
16 477
+7%
|
16 740
+2%
|
17 651
+5%
|
17 919
+2%
|
18 206
+2%
|
22 381
+23%
|
26 074
+17%
|
35 539
+36%
|
39 941
+12%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
85
|
85
|
85
|
84
|
80
|
77
|
77
|
77
|
155
|
155
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
